nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Approach in glucocorticoid-induced osteoporosis prevention: The EGEO study preliminary data
|
Migliaccio, S. |
|
2009 |
45 |
S3 |
p. S137- 1 p. |
artikel |
2 |
Assessment of risk of osteoporosis in a population of menopausal women by OsteoRisk in Brazil
|
Bueno, A.N. |
|
2009 |
45 |
S3 |
p. S137-S138 2 p. |
artikel |
3 |
Awareness of glucocorticoid-induced osteoporosis: Influence of gender
|
Mazziotti, G. |
|
2009 |
45 |
S3 |
p. S138- 1 p. |
artikel |
4 |
Bisphosphonates in GIO: Novel insights in their action
|
Moro, L. |
|
2009 |
45 |
S3 |
p. S124- 1 p. |
artikel |
5 |
Bone health in congenital adrenal hyperplasia
|
Thorén, M. |
|
2009 |
45 |
S3 |
p. S125-S126 2 p. |
artikel |
6 |
Bone involvement in subclinical Cushing syndrome
|
Scillitani, A. |
|
2009 |
45 |
S3 |
p. S127- 1 p. |
artikel |
7 |
Bone microarchitecture and the effects of bisphosphonate therapy
|
Dempster, D.W. |
|
2009 |
45 |
S3 |
p. S124-S125 2 p. |
artikel |
8 |
Bone mineral density according to answer IOF's one-minute osteoporosis risk test
|
Povoroznyuk, V.V. |
|
2009 |
45 |
S3 |
p. S138- 1 p. |
artikel |
9 |
Bone mineral density in rheumatoid arthritis: Effects of steroids and biologics and relationship with disease severity
|
Mirone, L. |
|
2009 |
45 |
S3 |
p. S138-S139 2 p. |
artikel |
10 |
Bortezomib and osteoblast cell lineage in myeloma bone disease
|
Zangari, M. |
|
2009 |
45 |
S3 |
p. S123- 1 p. |
artikel |
11 |
Comparison of GIO treatment with other osteoporosis treatment in the U. S. Veterans Affairs System
|
Adler, R.A. |
|
2009 |
45 |
S3 |
p. S139- 1 p. |
artikel |
12 |
Dexamethasone affects survival of human osteoblastic cells through survivin regulation
|
Rippo, M.R. |
|
2009 |
45 |
S3 |
p. S139-S140 2 p. |
artikel |
13 |
Does the hypothalamic–pituitary–adrenal (HPA) function influence bone loss in the early postmenopausal period? A prospective study in non-osteoporotic women
|
Osella, G. |
|
2009 |
45 |
S3 |
p. S140- 1 p. |
artikel |
14 |
DXA and QUS in the diagnosis of GIO
|
Gonnelli, S. |
|
2009 |
45 |
S3 |
p. S121-S123 3 p. |
artikel |
15 |
Editorial Board
|
|
|
2009 |
45 |
S3 |
p. i-ii nvt p. |
artikel |
16 |
Effects of intermediate doses of glucocorticoids on bone turnover and circulating Dkk-1, MIF, sRANKL and OPG in patients with interstitial lung disease. A three-month longitudinal study
|
Calzolari, G. |
|
2009 |
45 |
S3 |
p. S140- 1 p. |
artikel |
17 |
Guidelines for prevention and treatment of glucocorticoid-induced osteoporosis
|
Compston, J. |
|
2009 |
45 |
S3 |
p. S128-S129 2 p. |
artikel |
18 |
25-Hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in endogenous hypercortisolism
|
Sanguin, F. |
|
2009 |
45 |
S3 |
p. S145- 1 p. |
artikel |
19 |
Hypovitaminosis D and prevalence of vertebral fractures in women with GIO
|
Mazziotti, G. |
|
2009 |
45 |
S3 |
p. S140-S141 2 p. |
artikel |
20 |
Index Invited Presentations
|
|
|
2009 |
45 |
S3 |
p. S118-S119 2 p. |
artikel |
21 |
Index Oral Communications and Posters
|
|
|
2009 |
45 |
S3 |
p. S135-S136 2 p. |
artikel |
22 |
Influence of glucocorticoid replacement treatment on risk of vertebral fractures in patients with hypopituitarism
|
Porcelli, T. |
|
2009 |
45 |
S3 |
p. S141- 1 p. |
artikel |
23 |
Inhalatory steroids and bone: The EOLO study
|
Nuti, R. |
|
2009 |
45 |
S3 |
p. S126-S127 2 p. |
artikel |
24 |
Intermittent pamidronate therapy to treat corticosteroid induced osteoporosis
|
Povoroznyuk, V.V. |
|
2009 |
45 |
S3 |
p. S141-S142 2 p. |
artikel |
25 |
Is there a shift of 11β-Hydroxysteroid Dehydrogenase type 1 from bone to adipose compartment during glucocorticoid excess?
|
Camozzi, V. |
|
2009 |
45 |
S3 |
p. S142- 1 p. |
artikel |
26 |
Management of diabetes in steroid treated patients
|
Lauro, D. |
|
2009 |
45 |
S3 |
p. S129- 1 p. |
artikel |
27 |
Management of osteoporosis in patient with rheumatoid arthritis: Strategies for improvement
|
Md Yusof, M.Y. |
|
2009 |
45 |
S3 |
p. S142- 1 p. |
artikel |
28 |
Mechanisms of glucocorticoid-induced myopathy
|
Thissen, J.P. |
|
2009 |
45 |
S3 |
p. S123-S124 2 p. |
artikel |
29 |
New data on teriparatide treatment
|
Nuti, R. |
|
2009 |
45 |
S3 |
p. S133- 1 p. |
artikel |
30 |
Non-invasive assessment of bone strength in osteoporosis
|
Bouxsein, M.L. |
|
2009 |
45 |
S3 |
p. S124- 1 p. |
artikel |
31 |
[No title]
|
|
|
2009 |
45 |
S3 |
p. S117- 1 p. |
artikel |
32 |
Osteocyte function and glucocorticoids
|
Weinstein, R.S. |
|
2009 |
45 |
S3 |
p. S121- 1 p. |
artikel |
33 |
Oxidative stress, cell apoptosis, glucocorticoids and osteoporosis
|
Manolagas, S.C. |
|
2009 |
45 |
S3 |
p. S120- 1 p. |
artikel |
34 |
Pathogenesis of bisphosphonate-related osteonecrosis of the jaw (ONJ): Focus on osteoimmunology
|
Angeli, A. |
|
2009 |
45 |
S3 |
p. S128- 1 p. |
artikel |
35 |
Peculiarities of steroid osteoporosis in rheumatic patients in various age groups
|
Haroyan, A. |
|
2009 |
45 |
S3 |
p. S142-S143 2 p. |
artikel |
36 |
RANKL inhibition as a targeted approach in the management of osteoporosis
|
Giustina, A. |
|
2009 |
45 |
S3 |
p. S134- 1 p. |
artikel |
37 |
Regulatory networks in the control of osteoblast cell fate are influenced by glucocorticoids
|
Lian, J.B. |
|
2009 |
45 |
S3 |
p. S121- 1 p. |
artikel |
38 |
Risedronate clinical efficacy and bisphosphonate new effectiveness data from real world clinical practice
|
Thomas, T. |
|
2009 |
45 |
S3 |
p. S132-S133 2 p. |
artikel |
39 |
Role of Notch signaling in osteoblast differentiation and bone remodeling
|
Canalis, E. |
|
2009 |
45 |
S3 |
p. S120-S121 2 p. |
artikel |
40 |
SATELLITE SYMPOSIUM
|
|
|
2009 |
45 |
S3 |
p. S132- 1 p. |
artikel |
41 |
Secondary osteoporosis in children
|
Leonard, M.B. |
|
2009 |
45 |
S3 |
p. S125- 1 p. |
artikel |
42 |
Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis
|
Salvin, S. |
|
2009 |
45 |
S3 |
p. S143- 1 p. |
artikel |
43 |
Strontium ranelate in the therapeutic strategies for osteoporosis, including GIO
|
Reginster, J.Y. |
|
2009 |
45 |
S3 |
p. S131- 1 p. |
artikel |
44 |
Teriparatide in the treatment of glucocorticoid-induced osteoporosis
|
Bilezikian, J.P. |
|
2009 |
45 |
S3 |
p. S131- 1 p. |
artikel |
45 |
The GH–IGF-1 axis and GIO
|
Giustina, A. |
|
2009 |
45 |
S3 |
p. S125- 1 p. |
artikel |
46 |
The glucocorticoid receptor: One gene, many proteins — New mechanisms for tissue specific anti-inflammatory actions of glucocorticoids in health and disease
|
Cidlowski, J.A. |
|
2009 |
45 |
S3 |
p. S120- 1 p. |
artikel |
47 |
The RANKL/RANK/OPG pathway: Preclinical and clinical pharmacology with relevance to GIO
|
Ferrari, S. |
|
2009 |
45 |
S3 |
p. S132- 1 p. |
artikel |
48 |
The system of 11β-hydroxysteroid dehydrogenases: Relevance to inflammatory bone loss
|
Cooper, M.S. |
|
2009 |
45 |
S3 |
p. S123- 1 p. |
artikel |
49 |
Umbilical cord stroma as source of mesenchymal stem cells for bone regeneration
|
Ciavarella, S. |
|
2009 |
45 |
S3 |
p. S143-S144 2 p. |
artikel |
50 |
Update on glucocorticoid therapy in rheumatoid arthritis
|
Bianchi, G. |
|
2009 |
45 |
S3 |
p. S127-S128 2 p. |
artikel |
51 |
Use of teriparatide in osteoporosis due to active rheumatic diseases
|
Salvin, S. |
|
2009 |
45 |
S3 |
p. S144- 1 p. |
artikel |
52 |
Utility of QUS assessment in COPD patients treated with GCS: The EOLO study
|
Gonnelli, S. |
|
2009 |
45 |
S3 |
p. S144-S145 2 p. |
artikel |
53 |
Variations in cortisol sensitivity: The clinical implications of the polymorphisms in the glucocorticoid receptor gene
|
Lamberts, S.W.J. |
|
2009 |
45 |
S3 |
p. S129-S131 3 p. |
artikel |